R -- Professional, administrative, and management support services

The National Cancer Institute plans to negotiate a modification to an existing contract with the University of Iowa to extend efforts for the Developmental Therapeutics Program. The contract supports the development and manufacturing of oral dosage forms and will be expanded to include topical dosage forms produced under current Good Manufacturing Practice (cGMP) standards. These efforts focus on promising agents obtained through the Drug Development Program and the RAID initiative, ensuring preparedness for future clinical trial designs. The contract is not a request for proposal but a direct negotiation to enhance the ongoing work. This engagement falls under professional, administrative, and management support services and retains the original contract number N01-CM-07100. The modification aims to build on prior progress by addressing emerging needs in drug formulation and production, critical for advancing therapeutic research. Contact for further details is the contract specialist Kathy L Giuliano, and the contract is managed through the National Cancer Institute's administrative framework. Collect calls related to this contract will not be accepted.